Estudio de la actividad bactericida de la combinación amoxicilina/ácido clavulánico y sus posibles efectos ante la resistencia a betalactámicos de Streptococcus pneumoniae

Medicina Clinica

Volumn 110, Issue SUPPL. 1, 1998, Pages 12-15

  Prieto, José ^a   Frías, Jesús ^b   Alou, Luis ^a   Carcas, Antonio ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CLAVULANIC ACID; PENICILLIN BINDING PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHAGOCYTOSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; BETA-LACTAM RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 2542575692     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gemmell CG, Lorian V. Effects of low concentrations of antibiotics on bacterial ultrastructure, virulence, and susceptibility to immunodefenses: clinical significance. En: Lorian V, editor. Antibiotics in laboratory medicine. Baltimore: Williams & Wilkins, 1996; 397-452.
2. Aguilar L, Giménez MJ, Dal-Ré R. Una aproximación explicativa al mantenimiento de la eficacia terapéutica de las penicilinas freute a Streptococcus pneumoniae. Rev Esp Quimioterap 1996; 9: 260-265.
3. Hunter PA, Coleman K, Fisher J, Taylor D. In vitro synergistic properlies of clavulanic acid with ampicillin, amoxicillin and ticarcillin. J Antimicrob Chemother 1980; 6: 455-470.
4. Adam D, De Visser I, Koeppe P. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrob Agents Chemother 1982; 22: 353-357.
5. Martín M, Aguilar L, Balcabao IP, Gómez-Lus ML, Dal-Ré R, Prieto J. In vitro pharmacodynamic simulation of clavulanic acid concentrations: etfect on Staphylococcus aureus and Haemophilus influenzae β-iactamase activity. J Antimicrob Chemother 1997; 39: 290-292.
6. Aguilar L, Martin M, Balcabao IP, Gomez-Lus ML, Dal-Ré R, Prieto J. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of arnoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens Antimicrob Agents Chemother 1997; 41: 1.403-1.405.
7. Rolinson GN. A review of the microbiology of amoxycillin/clavulanic acid over the 15 year period 1978-1993. J Chemother 1994; 6: 283-318.
8. Severin A, Severina E, Tomasz A. Abnormal physiological properties and altered cell wall composition in Streptococcus pneumoniae grown in the presence of clavulanic acid. Antimicrob Agents Chemother 1997; 41: 504-510.
9. Densen P, Clark RA, Nanseef WM. Granulocytic phagocytes En: Mandell GL, Bennett JE, Dolin R, editores. Principles and practice of infectious diseases. Nueva York: Churchill Livingstone Inc., 1995: 78-101.
10. Gómez-Lus ML. Giménez MJ, Aguilar L, Martinez P, Prieto J. Velocidad y magnitud de actividad bacteriana de amoxicilina y cefotaxima frente a Streptococcus pneumoniae: posible trascendencia en la predicción de su eficacia. Rev Esp Quimioterap 1996; 9: 247-249.
11. Balcabao IP, Aguilar L, Martín M, García Y, Dal-Ré R, Prieto J. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: In vitro pharmacodynamic simulation. Antimicrob Agents Chemother 1996; 40: 2.904-2.906.
12. Aguilar L, Rosendo J, Balcabao IP, Martín M, Giménez MJ. Frias J et al. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase study. Antimicrob Agents Chemother 1997; 41: 1.389-1.391.
13. Kowalsky SF, Echols RM, McCormick EM. Comparative serum bactericidal activity of ceftizoxime/metronidazole, ceftizoxime, clindamycin, and mipenem against obligate anaerobic bacteria. J Antimicrob Chemother 1990; 25: 767-775.
14. Nicolle LE. Measurement and significance of antibiotic activity in the urine. En: Lorian V, editor. Antibiotics in laboratory medicine. Baltimore: Williams & Wilkins, 1996; 793-812.
15. Hakenbeck R, Tornette S, Adkinson NF. Interaction of non-lytic β-lactams with penicillin binding proteins in Streptococcus pneumoniae. J Gen Microbiol 1987; 133: 755-760.
16. Jabes D, Tomasz A. Lytic and bactericidal activity of FCE 22101. J Antimicrob Chemother 1989: 23 (Supl C): 75-83.
17. Martin M. Gómez-Lus ML, Aguilar L, Martínez P, Giménez MJ, Prieto J. Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity against Streptococcus pneumoniae Eur J Clin Microbiol infect Dis 1997; 16: 512-516.
18. Gomez-Lus ML, Martín M, Martínez P, Giménez MJ, Aguilar L, Prieto J. Early bactericidal activity of amoxicillin/clavulanic acid (AC) versus cefotaxime (CTX) against S. pneumoniae. Effect of polymorphonuclear cells (PM). J Clin Microbiol Infect 1997; 3 (Supl 2): 68.
19. Martin M, Gómez-Lus ML, Martínez P, Aguilar L, Dal-Ré R, Prieto J. Effect of polymorphonuclear neutrophils on amoxicillin and cefotaxime activity against Streptococcus pneumoniae. Glasgow: Abstracts of 1st European Congress of Chemotherapy, 1996; F129.
20. Gómez-Lus ML, Aguilar L, Martin M, Giménez MJ, Martinez P, Prieto J. Intracellular and extracellular killing of a penicillin-resistant, serotype-9 strain of Streptococcus pneumoniae by polymorphonuclear leukocytes in the presence of sub-inhibitory concentrations of clavulanic acid [carta]. J Antimicrob Chemother 1997; 40: 142-144.
21. Winkelstein JA. The role of complement in the host's defense against Streptococcus pneumoniae. Rev Infect Dis 1981; 3: 289-298.
22. Van den Broek PJ, Seymonsbergen EM. The influence of human granulocytes and monocytes of the antibacterial activity of cefetamet against Staphylococcus aureus. J Antimicrob Chemother 1995; 35: 611-622.
23. Milatovic D. Antibiotics and phagocytosis, Eur J Clin Microbiol 1983; 2: 414-425.
24. Amsterdam D. Assessing cidal activity of antimicrobial agents: problems and pitfalls. Antimicrob Newsletter 1990; 7: 49-56.
25. García-Rodriguez JA, Baquero F, García de Lomas J, Torrellas A Susceptibility of respiratory pathogens to 12 antimicrobials: a prospective, multicentre Spanish study. J Clin Microbiol Infect 1997; 3 (Supl 2): 71.
26. Pallerés R, Liñares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-480.
27. Garau J, Rodríguez-Créixems M, Pérez-Trallero E, Giménez MJ, Rodriguez M, Aguilar E et al. Penicillins (PEN) vs. 3rd generation cephalosporins (CEP) as monotherapy of bacteremic pneumococcal pneumonia (BPP). J Clin Microbiol Infect 1997; 3 (Supl 2): 129-130.
28. Nonomura N, Giebink GS, Juhn SK, Harada T, Aeppli D. The pathophysiology of Streptococcus pneumoniae otitis media: kinetics of middle ear biochemical and cytological host responses. Ann Otol Rhinol Laryngol 1991; 100: 235-243.